⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

AMRX News

Amneal Pharmaceuticals, Inc. Class A Common Stock

Amneal Announces BLA Submission of Biosimilar Candidate to XOLAIR® (omalizumab)